Gabrielle Alison Silver

Gabrielle Alison Silver is a declared insider of Opiant Pharmaceuticals, Inc. (board member), with filings sourced from SEC (Form 4). We count 16 filings; the first trade dates from 22 November 2019 and the latest from 2 March 2023.

Market trades split into 3 purchases (€76k) and 3 sales (€123k). Netting one side against the other leaves €48k of net selling. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 3 share grants and 5 option exercises.

A typical purchase (the median) is worth €22k. 3 out of 3 purchases came within 30 days of a purchase by at least one other insider of the same company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

On 3 March 2023 came the latest disclosure, a transaction for €37k in Opiant Pharmaceuticals, Inc. The latest purchase dates back some time: it was published 1,621 days ago, on 17 May 2022. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.